8-K: Trustfeed Corp. to Merge with Polomar Specialty Pharmacy in Reorganization

Trustfeed Corp. will merge with Polomar Specialty Pharmacy, with Polomar becoming a wholly-owned subsidiary and former Polomar members owning 75% of the combined company.

Summary

• Trustfeed Corp. has entered into a merger agreement with Polomar Specialty Pharmacy, where a subsidiary of Trustfeed will merge into Polomar.
• Polomar will become a wholly-owned subsidiary of Trustfeed, and the combined entity is expected to be renamed Polomar Health Services, Inc.
• Upon completion of the merger, former members of Polomar are expected to own 75% of Trustfeed, while current Trustfeed stockholders will own 25%.
• Each 1% of Polomar's outstanding membership interest will be converted into 357,414.14 shares of Trustfeed common stock.
• CWR 1, LLC, Trustfeed's majority owner, will convert its preferred stock to common stock and return shares to ensure a public float of at least 10% post-merger.
• The merger is subject to several conditions, including stockholder approval, accuracy of representations, regulatory approvals, and a PCAOB compliant audit of Polomar.
• Trustfeed will also need to implement a 10:1 reverse stock split, increase preferred stock shares, and change its name as part of the merger conditions.
• The merger agreement includes standard representations, warranties, and covenants, and it can be terminated under certain conditions, such as breaches of the agreement.

Sentiment

Score: 7

Explanation: The document outlines a significant strategic move for Trustfeed, with a clear plan for the merger. While there are risks and potential dilution for existing shareholders, the overall tone is positive, indicating a strategic growth opportunity.

Positives

• The merger will create a new entity with a significant ownership stake for Polomar's former members.
• The transaction is structured as a reorganization, which may have tax benefits.
• The merger is not subject to any financing conditions or contingencies.
• The board of directors of both companies have unanimously approved the merger agreement.
• The merger will result in a public float of at least 10% for the combined company.

Negatives

• The merger is subject to several conditions, including shareholder approval and a PCAOB compliant audit of Polomar.
• Current Trustfeed stockholders will see their ownership diluted to 25% of the combined company.
• The merger requires a 10:1 reverse stock split, which can negatively impact the share price.
• The company will need to change its name, which may require additional marketing and branding efforts.

Risks

• The merger may not be completed if the conditions are not met, including shareholder approval and regulatory approvals.
• There is a risk that the representations and warranties made by each company may not be accurate.
• The integration of Polomar's business into Trustfeed may not be successful.
• The company may not be able to realize the anticipated benefits of the transaction.
• There is a risk that the company may not be able to drive increased customer value and financial returns.

Future Outlook

The document contains forward-looking statements regarding the completion of the merger and the ability of the combined company to drive increased customer value and financial returns. However, these statements are subject to risks and uncertainties.

Management Comments

• The board of directors of the Company and the managers and members of Polomar unanimously approved the Merger Agreement and the transactions contemplated thereby.
• The Board and the executive officers of the Company immediately prior to the closing of the Merger will remain the same immediately after the Closing.

Industry Context

This merger reflects a trend of consolidation in the healthcare and pharmaceutical sectors, where companies are seeking to expand their market presence and service offerings through strategic acquisitions.

Comparison to Industry Standards

• The exchange ratio and ownership split are specific to this transaction and not directly comparable to industry standards.
• The requirement for a PCAOB compliant audit is standard for companies seeking to be listed on major exchanges.
• The reverse stock split is a common mechanism used by companies to increase their share price and meet listing requirements.
• The merger structure, with a subsidiary merging into the target company, is a common approach in corporate reorganizations.

Related Party Transactions

• An affiliate of CWR 1, LLC owns a majority of the membership interests of Polomar.

Stakeholder Impact

• Current Trustfeed stockholders will experience a dilution of their ownership to 25% of the combined company.
• Former Polomar members will become major shareholders in the combined entity, owning 75%.
• Employees of both companies may experience changes in their roles and responsibilities.
• Customers of both companies may see changes in the products and services offered.
• Creditors of both companies will be subject to the terms of the merger agreement.

Next Steps

• Obtain shareholder approval for the merger.
• Complete a PCAOB compliant audit of Polomar.
• Implement a 10:1 reverse stock split.
• Increase the number of preferred stock shares.
• Change the company name to Polomar Health Services, Inc.
• File all necessary regulatory documents.

Key Dates

Keywords

merger, acquisition, reorganization, pharmacy, healthcare, stock split, public float, shareholder approval, PCAOB audit, reverse stock split